Recuperación de las interacciones entre el haya (Fagus sylvatica) y los hongos ectomicorrícicos 140 años después del fin de la actividad minera

Even the increasing use of restoration, it does not always imply a shortterm answer in ecosystems that guarantees the recovery of their structure, functions, and services. So far, most studies evaluating ecosystem recovery have used metrics that ignore the complexity needed to structure communities of organisms that form ecosystems. Here, we analyze the recovery of species interactions (metric with a certain level of complexity) in a large time scale ('100 years). In particular, we characterized, using molecular identification, the ectomicorrhyzal (EcM) fungal communities present in 18 beech trees inside and seven outside an ancient iron in Navarra (northern Spain), in use from the XIV century until 140 years ago, as well as seven beech trees from a nearby oldgrowth forest. Species richness of EcM fungi was similar for the three locations, while differences were found for species composition in the area damaged by mining and compare to outside the mine and the reference beech forest. Our results suggest the need to assess ecosystem recovery with more complex metrics (e.g. architecture of interaction networks) in order to accurately estimate the real time required for ecosystems to fully recover. © 2019 Los Autores.Este trabajo ha sido financiado por el Plan Nacional de Investigación RETOS (CGL2015-70452-R) y la acreditación de excelencia “María de Maeztu” 2018-2022 (MDM-2017-0714). ARU fue financiada por el programa de becas predoctorales (2016) de la Fundación Tatiana Guzman el Bueno

Percepción del paciente quirúrgico acerca de la seguridad en el ámbito hospitalario

Introducción: La construcción de lazos entre los pacientes y los profesionales de la salud después de la presentación de un evento tiene   importancia crítica. El Foro Nacional para la Calidad recientemente publicó en su reporte (2010), “Prácticas Seguras para una Mejor Atención en Salud”, recomendando, que el paciente debe recibir información oportuna, transparente y clara en relación con lo que se refiere al evento adverso. Objetivos: Determinar la percepción de seguridad que tienen los pacientes con la atención de la salud, identificar el número de pacientes que refieran haber sufrido un error y las respuestas a las preguntas de cómo se resolvió el error durante su hospitalización el servicio de cirugía de un hospital de seguridad social. Materiales y Métodos: Diseño descriptivo, población 127 pacientes hospitalizados en el servicio de cirugía, que cumplieron con los criterios de inclusión. Resultados y Discusión: La media de percepción fue de 40.77 con una (DE=8.37). Los errores que refirieron los pacientes fueron: Infección 7.1 %, 4.75 % reacción alérgica, 10.2 %   intervenido por segunda ocasión y 100% de los pacientes contestaron no haberse caído. El 1.6% (2) estuvo completamente de acuerdo al preguntarles si se resolvió satisfactoriamente el error, el 3.1% mencionó que el error se resolvió rápido, 1.6% (2) mencionó estar completamente de acuerdo referente a la información recibida acerca del error. El 2.4% (3) de los pacientes contestaron en desacuerdo respecto a la información de si se tomarían medidas para evitar que el error se volviera a presentar. Conclusiones: La mayoría de los pacientes refirieron percibirse seguros durante su hospitalización, un porcentaje menor mencionó haber tenido incidentes y al preguntarles sobre si se habían sentido seguros durante su estancia hospitalaria la mayoría dijo haberse sentido bastantes seguros.Cómo citar este artículo: Meléndez C, Garza R, Castañeda-Hidalgo H, González JF, Turrubiates J. Percepción del paciente quirúrgico acerca de la seguridad en el ámbito hospitalario. Rev Cuid. 2015; 6(2): 1054-61. http://dx.doi.org/10.15649/cuidarte.v6i2.16

Efecto de la inoculación con hongos micorrízicos en el rendimiento de avena forrajera

Objective: The objective of the present study was to evaluate the effect of inoculation with two species of mycorrhizal fungi on the yield of forage oats. Design / methodology / approach: The method of pelletization and seed coating was used; The sowing went to volley. A completely randomized design with factorial arrangement (2x3x3) was used as factors: the two varieties, the HMA Glomus cubense and Glomus fasciculatum with a control and fertilization at 50% and 100% with a control with four repetitions. Results: The Chihuahua variety obtained a better yield, leaf stem ratio, leaf area index, number of leaves, leaf death, stem density and leaf death (2.50); in the other variables they were statistically equal. The Glomus cubense species was superior to Glomus fasciculatum in the yield variables (6.92 t DM ha-1) and in the death of leaves (4.68), but in the leaf area index (135.02), Glomus fasciculatum exceeded Glomus cubense. Limitations of the study / implications: yield in fodder production, producers apply high amounts of chemical fertilizers, whose excessive use negatively affects the soil resource. Findings / conclusions: The Chihuahua variety has better behavior and Glomus cubense exceeds Glomus fascicucatum in performanceObjetivo: El objetivo del presente estudio fue evaluar el efecto de inoculación con dos especies de hongos micorrízicos en el rendimiento de avena forrajera. Diseño/metodología/aproximación: Se utilizó el método de peletización y recubrimiento de semilla; la siembra fue al voleo. Se utilizó un diseño completamente al azar con arreglo factorial (2x3x3) se consideró como factores: las dos variedades, los HMA Glomus cubense y Glomus fasciculatum con un testigo y la fertilización al 50% y al 100% con un testigo con cuatro repeticiones. Resultados: La variedad Chihuahua obtuvo un mejor rendimiento, relación hoja tallo, índice de área foliar, número de hojas, muerte de hojas, densidad de tallos y en la muerte de hojas (2.50); en las demás variables fueron estadísticamente iguales. La especie Glomus cubense fue superior al Glomus fasciculatum en las variables rendimiento (6.92 t MS ha-1) y en la muerte de hojas (4.68), pero en el índice de área foliar (135.02), Glomus fasciculatum superó a Glomus cubense. Limitaciones del estudio/implicaciones: el rendimiento en la producción de forraje, los productores aplican cantidades elevadas de fertilizantes químicos, cuyo uso excesivo afecta negativamente el recurso suelo. Hallazgos/conclusiones: La variedad Chihuahua tiene mejor comportamiento y Glomus cubense en supera en rendimiento a Glomus fascicucatu

Dynamic arrest in charged colloidal systems exhibiting large-scale structural heterogeneities

Suspensions of charged liposomes are found to exhibit typical features of strongly repulsive fluid systems at short length scales, while exhibiting structural heterogeneities at larger length scales that are characteristic of attractive systems. We model the static structure factor of these systems using effective pair interaction potentials composed of a long-range attraction and a shorter range repulsion. Our modeling of the static structure yields conditions for dynamically arrested states at larger volume fractions, which we find to agree with the experimentally observed dynamics

Identification and quantification of microplastics in wastewater using focal plane array-based reflectance micro-FT-IR imaging

Microplastics (<5 mm) have been documented in environmental samples on a global scale. While these pollutants may enter aquatic environments via wastewater treatment facilities, the abundance of microplastics in these matrices has not been investigated. Although efficient methods for the analysis of microplastics in sediment samples and marine organisms have been published, no methods have been developed for detecting these pollutants within organic-rich wastewater samples. In addition, there is no standardized method for analyzing microplastics isolated from environmental samples. In many cases, part of the identification protocol relies on visual selection before analysis, which is open to bias. In order to address this, a new method for the analysis of microplastics in wastewater was developed. A pretreatment step using 30% hydrogen peroxide (H2O2) was employed to remove biogenic material, and focal plane array (FPA)-based reflectance micro-Fourier-transform (FT-IR) imaging was shown to successfully image and identify different microplastic types (polyethylene, polypropylene, nylon-6, polyvinyl chloride, polystyrene). Microplastic-spiked wastewater samples were used to validate the methodology, resulting in a robust protocol which was nonselective and reproducible (the overall success identification rate was 98.33%). The use of FPA-based micro-FT-IR spectroscopy also provides a considerable reduction in analysis time compared with previous methods, since samples that could take several days to be mapped using a single-element detector can now be imaged in less than 9 h (circular filter with a diameter of 47 mm). This method for identifying and quantifying microplastics in wastewater is likely to provide an essential tool for further research into the pathways by which microplastics enter the environment.This work is funded by a NERC (Natural Environment Research Council) CASE studentship (NE/K007521/1) with contribution from industrial partner Fera Science Ltd., United Kingdom. The authors would like to thank Peter Vale, from Severn Trent Water Ltd, for providing access to and additionally Ashley Howkins (Brunel University London) for providing travel and assistance with the sampling of the Severn Trent wastewater treatment plant in Derbyshire, UK. We are grateful to Emma Bradley and Chris Sinclair for providing helpful suggestions for our research

Effect of the aniline fragment in Pt(II) and Pt(IV) complexes as anti-proliferative agents. Standard reduction potential as a more reliable parameter for Pt(IV) compounds than peak reduction potential

The problems of resistance and side effects associated with cisplatin and other chemotherapeutic drugs have boosted research aimed at finding new compounds with improved properties. The use of platinum(IV) prodrugs is one alternative, although there is some controversy regarding the predictive ability of the peak reduction potentials. In the work described here a series of fourteen chloride Pt(II) and Pt(IV) compounds was synthesised and fully characterised. The compounds contain different bidentate arylazole heterocyclic ligands. Their cytotoxic properties against human lung carcinoma (A549), human breast carcinoma (MCF7) and human colon carcinoma (HCT116 and HT29) cell lines were studied. A clear relationship between the type of ligand and the anti-proliferative properties was found, with the best results obtained for the Pt(II) compound that contains an aniline fragment, (13), thus evidencing a positive effect of the NH2 group. Stability and aquation studies in DMSO, DMF and DMSO/water mixtures were carried out on the active complexes and an in-depth analysis of the two aquation processes, including DFT analysis, of 13 was undertaken. It was verified that DNA was the target and that cell death occurred by apoptosis in the case of 13. Furthermore, the cytotoxic derivatives did not exhibit haemolytic activity. The reduction of the Pt(IV) compounds whose Pt(II) congeners were active was studied by several techniques. It was concluded that the peak reduction potential was not useful to predict the ability for reduction. However, a correlation between the cytotoxic activity and the standard reduction potential was found.This work has been funded by the Spanish Ministerio de Ciencia, Innovación y Universidades (MCIU), Agencia Estatal de Investigación (AEI) and Fondo Europeo de Desarrollo Regional (FEDER) (RTI2018-100709-B-C21 to BRM, RTI2018-100709-B-C22 to AM, RTI2018-094093-B-I00 to RSP), Junta de Comunidades de Castilla-La Mancha-FEDER (JCCM) (grant SBPLY/19/180501/000260 to BRM), Ministerio de Economía y Competitividad (Project PID2019-104381GB-I00 to GC), Fundación Leticia Castillejo Castillo to MJRH, Junta de Castilla y León, Consejería de Educación y Cultura y Fondo Social Europeo (Projects BU263P18 and BU087G19 to JVC) as well as UCLM-FEDER (grants 2019-GRIN-27183 and 2019-GRIN-27209 to BRM) and University of Girona (MPCUdG2016/076 to AM)

BioTIME: A database of biodiversity time series for the Anthropocene.

MotivationThe BioTIME database contains raw data on species identities and abundances in ecological assemblages through time. These data enable users to calculate temporal trends in biodiversity within and amongst assemblages using a broad range of metrics. BioTIME is being developed as a community-led open-source database of biodiversity time series. Our goal is to accelerate and facilitate quantitative analysis of temporal patterns of biodiversity in the Anthropocene.Main types of variables includedThe database contains 8,777,413 species abundance records, from assemblages consistently sampled for a minimum of 2 years, which need not necessarily be consecutive. In addition, the database contains metadata relating to sampling methodology and contextual information about each record.Spatial location and grainBioTIME is a global database of 547,161 unique sampling locations spanning the marine, freshwater and terrestrial realms. Grain size varies across datasets from 0.0000000158 km2 (158 cm2) to 100 km2 (1,000,000,000,000 cm2).Time period and grainBioTIME records span from 1874 to 2016. The minimal temporal grain across all datasets in BioTIME is a year.Major taxa and level of measurementBioTIME includes data from 44,440 species across the plant and animal kingdoms, ranging from plants, plankton and terrestrial invertebrates to small and large vertebrates.Software format.csv and .SQL

Un examen actualizado de la percepción de las barreras para la implementación de la farmacogenómica y la utilidad de los pares fármaco/gen en América Latina y el Caribe

La farmacogenómica (PGx) se considera un campo emergente en los países en desarrollo. La investigación sobre PGx en la región de América Latina y el Caribe (ALC) sigue siendo escasa, con información limitada en algunas poblaciones. Por lo tanto, las extrapolaciones son complicadas, especialmente en poblaciones mixtas. En este trabajo, revisamos y analizamos el conocimiento farmacogenómico entre la comunidad científica y clínica de ALC y examinamos las barreras para la aplicación clínica. Realizamos una búsqueda de publicaciones y ensayos clínicos en este campo en todo el mundo y evaluamos la contribución de ALC. A continuación, realizamos una encuesta regional estructurada que evaluó una lista de 14 barreras potenciales para la aplicación clínica de biomarcadores en función de su importancia. Además, se analizó una lista emparejada de 54 genes/fármacos para determinar una asociación entre los biomarcadores y la respuesta a la medicina genómica. Esta encuesta se comparó con una encuesta anterior realizada en 2014 para evaluar el progreso en la región. Los resultados de la búsqueda indicaron que los países de América Latina y el Caribe han contribuido con el 3,44% del total de publicaciones y el 2,45% de los ensayos clínicos relacionados con PGx en todo el mundo hasta el momento. Un total de 106 profesionales de 17 países respondieron a la encuesta. Se identificaron seis grandes grupos de obstáculos. A pesar de los continuos esfuerzos de la región en la última década, la principal barrera para la implementación de PGx en ALC sigue siendo la misma, la "necesidad de directrices, procesos y protocolos para la aplicación clínica de la farmacogenética/farmacogenómica". Las cuestiones de coste-eficacia se consideran factores críticos en la región. Los puntos relacionados con la reticencia de los clínicos son actualmente menos relevantes. Según los resultados de la encuesta, los pares gen/fármaco mejor clasificados (96%-99%) y percibidos como importantes fueron CYP2D6/tamoxifeno, CYP3A5/tacrolimus, CYP2D6/opioides, DPYD/fluoropirimidinas, TMPT/tiopurinas, CYP2D6/antidepresivos tricíclicos, CYP2C19/antidepresivos tricíclicos, NUDT15/tiopurinas, CYP2B6/efavirenz y CYP2C19/clopidogrel. En conclusión, aunque la contribución global de los países de ALC sigue siendo baja en el campo del PGx, se ha observado una mejora relevante en la región. La percepción de la utilidad de las pruebas PGx en la comunidad biomédica ha cambiado drásticamente, aumentando la concienciación entre los médicos, lo que sugiere un futuro prometedor en las aplicaciones clínicas de PGx en ALC.Pharmacogenomics (PGx) is considered an emergent field in developing countries. Research on PGx in the Latin American and the Caribbean (LAC) region remains scarce, with limited information in some populations. Thus, extrapolations are complicated, especially in mixed populations. In this paper, we reviewed and analyzed pharmacogenomic knowledge among the LAC scientific and clinical community and examined barriers to clinical application. We performed a search for publications and clinical trials in the field worldwide and evaluated the contribution of LAC. Next, we conducted a regional structured survey that evaluated a list of 14 potential barriers to the clinical implementation of biomarkers based on their importance. In addition, a paired list of 54 genes/drugs was analyzed to determine an association between biomarkers and response to genomic medicine. This survey was compared to a previous survey performed in 2014 to assess progress in the region. The search results indicated that Latin American and Caribbean countries have contributed 3.44% of the total publications and 2.45% of the PGx-related clinical trials worldwide thus far. A total of 106 professionals from 17 countries answered the survey. Six major groups of barriers were identified. Despite the region’s continuous efforts in the last decade, the primary barrier to PGx implementation in LAC remains the same, the “need for guidelines, processes, and protocols for the clinical application of pharmacogenetics/pharmacogenomics”. Cost-effectiveness issues are considered critical factors in the region. Items related to the reluctance of clinicians are currently less relevant. Based on the survey results, the highest ranked (96%–99%) gene/drug pairs perceived as important were CYP2D6/tamoxifen, CYP3A5/tacrolimus, CYP2D6/opioids, DPYD/fluoropyrimidines, TMPT/thiopurines, CYP2D6/tricyclic antidepressants, CYP2C19/tricyclic antidepressants, NUDT15/thiopurines, CYP2B6/efavirenz, and CYP2C19/clopidogrel. In conclusion, although the global contribution of LAC countries remains low in the PGx field, a relevant improvement has been observed in the region. The perception of the usefulness of PGx tests in biomedical community has drastically changed, raising awareness among physicians, which suggests a promising future in the clinical applications of PGx in LAC

Gaia Early Data Release 3 Acceleration of the Solar System from Gaia astrometry

Context. Gaia Early Data Release 3 (Gaia EDR3) provides accurate astrometry for about 1.6 million compact (QSO-like) extragalactic sources, 1.2 million of which have the best-quality five-parameter astrometric solutions. Aims. The proper motions of QSO-like sources are used to reveal a systematic pattern due to the acceleration of the solar systembarycentre with respect to the rest frame of the Universe. Apart from being an important scientific result by itself, the acceleration measured in this way is a good quality indicator of the Gaia astrometric solution. Methods. Theeffect of the acceleration was obtained as a part of the general expansion of the vector field of proper motions in vector spherical harmonics (VSH). Various versions of the VSH fit and various subsets of the sources were tried and compared to get the most consistent result and a realistic estimate of its uncertainty. Additional tests with the Gaia astrometric solution were used to get a better idea of the possible systematic errors in the estimate. Results. Our best estimate of the acceleration based on Gaia EDR3 is (2.32 +/- 0.16) x 10(-10) m s(-2) (or 7.33 +/- 0.51 km s(-1) Myr-1) towards alpha = 269.1 degrees +/- 5.4 degrees, delta = -31.6 degrees +/- 4.1 degrees, corresponding to a proper motion amplitude of 5.05 +/- 0.35 mu as yr(-1). This is in good agreement with the acceleration expected from current models of the Galactic gravitational potential. We expect that future Gaia data releases will provide estimates of the acceleration with uncertainties substantially below 0.1 mu as yr(-1).Peer reviewe